Changzhou Niujin Shisong Biotechnology Company Ltd.

Home > PRODUCT& SERVICE > Recombinant Overlapping Peptid
Recombinant Overlapping peptides of HPV18E7
Details

 

Product Introduction

Number of Amino acids

183

Molecular Weight

21kDa

Purity(SDS-PAGE)

≥70%

Endotoxin

10EU/mg

Storage condition

-20℃

Formulation

PBS(7.4)

Packing

Tube

 

 

Functional Properties 

Cervical cancer is one of the most common malignant tumors caused by HIGH-RISK HPV. HPV infection is the primary and initial factors resulting in Cervical cancer, HPV16 and HPV18 are the major types.

We have developed a new technique, Recombinant Overlapping peptides, to stimulate and monitor the immune response of CD8+ and CD4+ T cells.

Related Papers

Cai L, Zhang J, Zhu R, et al. Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins[J]. Oncotarget, 2017, 8(44):76516-76524.